Skip to main content

Greene Donna Cullen's Form 4 filing

Nextgen Healthcare, Inc. (NXGN) · filed Mar 4, 2022

Accession no.
0001209191-22-016474
Filed
Mar 4, 2022
Trade date
Mar 3, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $1.28M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Greene Donna CullenCIK 0001871873Officer (EVP, Human Resources)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 3, 2022Common StockMOption exerciseAcquired+10,000$16.64+$166,40069,460Direct
Mar 3, 2022Common StockMOption exerciseAcquired+6,625$12.78+$84,667.576,085Direct
Mar 3, 2022Common StockMOption exerciseAcquired+17,000$16.37+$278,29093,085Direct
Mar 3, 2022Common StockMOption exerciseAcquired+30,000$14.38+$431,400123,085Direct
Mar 3, 2022Common StockSSaleDisposed−63,625$20.05F1−$1,275,681.2559,460Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 3, 2022Common StockMOption exerciseDisposed−10,000$0.00$053,625Direct
Mar 3, 2022Common StockMOption exerciseDisposed−6,625$0.00$047,000Direct
Mar 3, 2022Common StockMOption exerciseDisposed−17,000$0.00$030,000Direct
Mar 3, 2022Common StockMOption exerciseDisposed−30,000$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.16 to $19.99. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)